Abstract: . . .  Ethics in Science and New Technologies. Retrieved February 2, 2005, from www.genethics.ca/patent.html . Nuffield Council on Bioethics (2002). Ethics of Patenting DNA: A Discussion Paper. London: Nuffield Foundation. Willison, D.J. and S.M. Macleod (August 2002). Patenting of Genetic Material: Are the Benefits to Society Being Realized? Canadian Medical Association Journal, 167 (3), 259-262. Retrieved February 2, 2005, from http://www.cmaj.ca/cgi/content/full/167/3/259 .  . . .
. . .  necessary prices for new products (34% strongly agree) (Environics, 1998). Most Canadians associate genome research with medical products and have indicated in a national survey that equality of access should be the primary guiding principle in commercialization, including the patenting of products (Einsiedel and Sheremeta, 2005). Most express strong views that the cost of pharmaceuticals cannot dictate who receives them, and that those of average means should not suffer financial hardship to obtain Page 15 - 9 - them. A majority believes the patenting of genetic information will lead to both of these problems (Earnscliffe and Pollara, 2000b). In the life sciences . . .
. . .  Attention to Europe and Canada. Report prepared for the European Group on Ethics in Science and New Technologies. Retrieved February 2, 2005, from www.genethics.ca/patent.html . Nuffield Council on Bioethics (2002). Ethics of Patenting DNA: A Discussion Paper. London: Nuffield Foundation. Willison, D.J. and S.M. Macleod (August 2002). Patenting of Genetic Material: Are the Benefits to Society Being Realized? Canadian Medical Association Journal, 167 (3), 259-262. Retrieved February 2, 2005, from http://www.cmaj.ca/cgi/content/full/167/3/259 .  . . .
. . .  Gaskell, G., E. Einsiedel, S. Priest, T. TenEyck, N. Allum, and H. Torgersen (2001), “Troubled waters: the Atlantic divide on Biotechnology policy”. In G. Gaskell and M. Bauer (eds.). Biotechnology 1996-2000: the years of controversy. London: Science Museum. Gold, E. R. (December 2000). Patents in Genes. Report prepared for the Canadian Biotechnology Advisory Committee Project Steering Committee on Intellectual Property and the Patenting of Higher Life Forms. Retrieved February 2, 2005, from www.cbac-cccb.ca , Publications, Research. Government of Ontario (January 2002). Genetics, Testing and Gene Patenting: Charting New Territory in Healthcare. Report to the Provinces and Territories. . . .
--3000,4,375,2967,54653